JP2022068197A5 - - Google Patents

Download PDF

Info

Publication number
JP2022068197A5
JP2022068197A5 JP2022014178A JP2022014178A JP2022068197A5 JP 2022068197 A5 JP2022068197 A5 JP 2022068197A5 JP 2022014178 A JP2022014178 A JP 2022014178A JP 2022014178 A JP2022014178 A JP 2022014178A JP 2022068197 A5 JP2022068197 A5 JP 2022068197A5
Authority
JP
Japan
Prior art keywords
examples
prepared
same procedure
procedure
same
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Granted
Application number
JP2022014178A
Other languages
English (en)
Japanese (ja)
Other versions
JP2022068197A (ja
JP7781660B2 (ja
Filing date
Publication date
Priority claimed from PCT/US2018/022049 external-priority patent/WO2018169880A1/en
Application filed filed Critical
Publication of JP2022068197A publication Critical patent/JP2022068197A/ja
Publication of JP2022068197A5 publication Critical patent/JP2022068197A5/ja
Application granted granted Critical
Publication of JP7781660B2 publication Critical patent/JP7781660B2/ja
Active legal-status Critical Current
Anticipated expiration legal-status Critical

Links

JP2022014178A 2017-03-13 2022-02-01 デュアルmagl及びfaahインヒビター Active JP7781660B2 (ja)

Applications Claiming Priority (4)

Application Number Priority Date Filing Date Title
US201762470830P 2017-03-13 2017-03-13
US62/470,830 2017-03-13
PCT/US2018/022049 WO2018169880A1 (en) 2017-03-13 2018-03-12 Dual magl and faah inhibitors
JP2019572352A JP7178375B2 (ja) 2017-03-13 2018-03-12 デュアルmagl及びfaahインヒビター

Related Parent Applications (1)

Application Number Title Priority Date Filing Date
JP2019572352A Division JP7178375B2 (ja) 2017-03-13 2018-03-12 デュアルmagl及びfaahインヒビター

Publications (3)

Publication Number Publication Date
JP2022068197A JP2022068197A (ja) 2022-05-09
JP2022068197A5 true JP2022068197A5 (enExample) 2022-06-30
JP7781660B2 JP7781660B2 (ja) 2025-12-08

Family

ID=63445929

Family Applications (4)

Application Number Title Priority Date Filing Date
JP2019572352A Active JP7178375B2 (ja) 2017-03-13 2018-03-12 デュアルmagl及びfaahインヒビター
JP2022014178A Active JP7781660B2 (ja) 2017-03-13 2022-02-01 デュアルmagl及びfaahインヒビター
JP2022105683A Active JP7440572B2 (ja) 2017-03-13 2022-06-30 デュアルmagl及びfaahインヒビター
JP2024020785A Pending JP2024056887A (ja) 2017-03-13 2024-02-15 デュアルmagl及びfaahインヒビター

Family Applications Before (1)

Application Number Title Priority Date Filing Date
JP2019572352A Active JP7178375B2 (ja) 2017-03-13 2018-03-12 デュアルmagl及びfaahインヒビター

Family Applications After (2)

Application Number Title Priority Date Filing Date
JP2022105683A Active JP7440572B2 (ja) 2017-03-13 2022-06-30 デュアルmagl及びfaahインヒビター
JP2024020785A Pending JP2024056887A (ja) 2017-03-13 2024-02-15 デュアルmagl及びfaahインヒビター

Country Status (31)

Country Link
US (4) US10350205B2 (enExample)
EP (3) EP4424683A3 (enExample)
JP (4) JP7178375B2 (enExample)
KR (3) KR102613364B1 (enExample)
CN (5) CN117736178B (enExample)
AR (2) AR111271A1 (enExample)
AU (3) AU2018236161B9 (enExample)
CA (1) CA3056076A1 (enExample)
CL (1) CL2019002583A1 (enExample)
CO (1) CO2019009932A2 (enExample)
DK (1) DK3595665T3 (enExample)
EA (1) EA201991898A1 (enExample)
EC (1) ECSP19066721A (enExample)
ES (1) ES2994239T3 (enExample)
FI (1) FI3595665T3 (enExample)
HR (1) HRP20241558T1 (enExample)
HU (1) HUE069115T2 (enExample)
IL (3) IL311446B2 (enExample)
LT (1) LT3595665T (enExample)
MX (1) MX2022006862A (enExample)
NZ (1) NZ756915A (enExample)
PL (1) PL3595665T3 (enExample)
PT (1) PT3595665T (enExample)
RS (1) RS66192B1 (enExample)
SA (2) SA519410101B1 (enExample)
SG (1) SG11201908159QA (enExample)
SI (1) SI3595665T1 (enExample)
SM (1) SMT202400468T1 (enExample)
TW (2) TWI797111B (enExample)
WO (1) WO2018169880A1 (enExample)
ZA (1) ZA201905934B (enExample)

Families Citing this family (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
PL2800565T3 (pl) 2012-01-06 2020-09-21 Lundbeck La Jolla Research Center, Inc. Związki karbaminianowe i sposoby ich wytwarzania oraz zastosowanie
JOP20190107A1 (ar) 2016-11-16 2019-05-09 Lundbeck La Jolla Research Center Inc مثبطات أحادي أسيل جليسرول ليباز (magl)
EA201991898A1 (ru) * 2017-03-13 2020-02-07 Эбайд Терапьютикс, Инк. Двойные ингибиторы magl и faah
PL3849970T3 (pl) * 2018-09-13 2025-01-07 Celgene Corporation Krystaliczny (r)-5-karbamoilopirydyn-3-ylo-2-metylo-4-(3-(trifluorometoksy)benzylo)piperazyno-1-karboksylan, kompozycje i sposoby ich zastosowania
MX2024008337A (es) 2021-12-29 2024-07-30 Psy Therapeutics Inc Inhibicion de la monoacilglicerol lipasa (magl).
JP2023158385A (ja) * 2022-04-18 2023-10-30 株式会社三洋物産 遊技機
JP2023158388A (ja) * 2022-04-18 2023-10-30 株式会社三洋物産 遊技機
JP2023158387A (ja) * 2022-04-18 2023-10-30 株式会社三洋物産 遊技機

Family Cites Families (24)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP1636187A1 (en) * 2003-06-12 2006-03-22 Novo Nordisk A/S Substituted piperazine carbamates for use as inhibitors of hormone sensitive lipase
KR20060021881A (ko) * 2003-06-12 2006-03-08 노보 노르디스크 에이/에스 호르몬 민감성 리파제의 억제제로서의 사용을 위한 치환된피페리딘 카르바메이트
JP2006088075A (ja) * 2004-09-27 2006-04-06 Kubota Corp 脱臭装置
EP2607362B1 (en) 2005-02-17 2014-12-31 Astellas Pharma Inc. Piperidine and piperazine carboxylates as FAAH inhibitors
WO2006101858A1 (en) 2005-03-18 2006-09-28 Institute For Chemical Genomics Alpha-helix mimetics and methods relating to the treatment of fibrosis
EP2373315A4 (en) 2008-11-14 2012-06-27 Scripps Research Inst METHOD AND COMPOSITIONS RELATED TO TARGETING OF MONOACYLGLYCEROLLIPASE
WO2010068453A1 (en) * 2008-11-25 2010-06-17 Janssen Pharmaceutica Nv Heteroaryl-substituted urea modulators of fatty acid amide hydrolase
FR2941696B1 (fr) 2009-02-05 2011-04-15 Sanofi Aventis Derives d'azaspiranyl-alkylcarbamates d'heterocycles a 5 chainons, leur preparation et leur application en therapeutique
FR2945531A1 (fr) * 2009-05-12 2010-11-19 Sanofi Aventis Derives de 7-aza-spiro°3,5!nonane-7-carboxylates, leur preparation et leur application en therapeutique
WO2010141817A1 (en) * 2009-06-05 2010-12-09 Janssen Pharmaceutica Nv Heteroaryl-substituted spirocyclic diamine urea modulators of fatty acid amide hydrolase
BR112012018913A2 (pt) * 2010-01-28 2017-06-20 Merck Sharp & Dohme "composição farmacêutica, e, uso da composição"
JP2013147430A (ja) * 2010-04-28 2013-08-01 Astellas Pharma Inc 夜間頻尿の予防又は治療剤
TW201206440A (en) 2010-04-28 2012-02-16 Astellas Pharma Inc Prophylactic or therapeutic agent for diseases associated with pains in urinary organs
PL2800565T3 (pl) 2012-01-06 2020-09-21 Lundbeck La Jolla Research Center, Inc. Związki karbaminianowe i sposoby ich wytwarzania oraz zastosowanie
NZ723198A (en) 2012-11-20 2018-11-30 Boehringer Ingelheim Animal Health Usa Inc Anthelmintic compounds and compositions and methods of using thereof
EP2956441A4 (en) 2013-02-18 2016-11-02 Scripps Research Inst MODULATORS OF VASOPRESSIN RECEPTORS WITH THERAPEUTIC POTENTIAL
WO2015003002A1 (en) 2013-07-03 2015-01-08 Abide Therapeutics, Inc. Pyrrolo-pyrrole carbamate and related organic compounds, pharmaceutical compositions, and medical uses thereof
JP2017505777A (ja) 2014-01-29 2017-02-23 シンタ ファーマスーティカルズ コーポレーション 標的化治療薬
WO2016014975A2 (en) 2014-07-25 2016-01-28 Northeastern University Urea/carbamates faah magl or dual faah/magl inhibitors and uses thereof
MX2017011997A (es) * 2015-03-18 2018-05-28 Abide Therapeutics Inc Carbamatos de piperacina y metodos de preparacion y uso.
PE20180694A1 (es) * 2015-07-31 2018-04-23 Pfizer Derivados de 1,1,1-trifluoro-3-hidroxipropan-2-il-carbamato y derivados de 1,1,1-trifluoro-4-hidroxibutan-2-il-carbamato como inhibidores de magl
ES2861648T3 (es) 2016-05-12 2021-10-06 Lundbeck La Jolla Research Center Inc Compuestos de espirociclo y procedimientos de fabricación y uso de los mismos
EA201991898A1 (ru) 2017-03-13 2020-02-07 Эбайд Терапьютикс, Инк. Двойные ингибиторы magl и faah
HU231058B1 (hu) 2017-03-13 2020-04-28 Richter Gedeon Nyrt. Gyógyászatilag hatékony aliciklusos-szubsztituált pirazolo[1,5-a]pirimidin származékok

Similar Documents

Publication Publication Date Title
JP2022068197A5 (enExample)
JPWO2019193209A5 (enExample)
JPWO2019193210A5 (enExample)
JPWO2019193208A5 (enExample)
JP2021008630A5 (enExample)
JP2009523455A5 (enExample)
JP2015532666A5 (enExample)
JP2020175021A5 (enExample)
JPWO2022202973A5 (enExample)
JP2019089762A5 (enExample)
JP2020183924A5 (enExample)
JP2018186811A5 (enExample)
JPWO2021152968A5 (enExample)
JP2020049413A5 (enExample)
JP2007500762A5 (enExample)
JP2020180208A5 (enExample)
JP2019210167A5 (enExample)
JP2022144517A5 (enExample)
JP2019218238A5 (enExample)
JP2019073673A5 (enExample)
JP2020135963A5 (enExample)
JPWO2022054956A5 (enExample)
JP2023178005A5 (enExample)
JPWO2022172850A5 (enExample)
JP2020201325A5 (enExample)